Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Shabsigh

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Prostate Cancer|January 19, 2026
Change in Clinical Management of Localized Prostate Cancer Patients at a Tertiary Medical Center as a Result of SARS-CoV-2 (COVID-19)Alexander Yaney, Jonathan E Schoenhals, Yevgeniya Gokun, et al.
Cells|June 26, 2024
Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer ResearchAbdalla Elbialy, Deepthi Kappala, Dhruv Desai, et al.
World Journal of Urology|February 25, 2019
Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomyMichael A Feuerstein, Leah Goldstein, Brieyona Reaves, et al.
The Journal of Urology|January 4, 2020
Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial CarcinomaBeat Foerster, Mohammad Abufaraj, Firas Petros, et al.
JAMA Network Open|February 16, 2022
Comparison of Robot-Assisted and Open Radical Cystectomy in Recovery of Patient-Reported and Performance-Related Measures of Independence: A Secondary Analysis of a Randomized Clinical TrialVivek Venkatramani, Isildinha M Reis, Mark L Gonzalgo, et al.
BJU International|January 28, 2015
The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial updateNorm D Smith, Erik P Castle, Mark L Gonzalgo, et al.
The Journal of Urology|April 10, 2020
Health Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial: A Multi-Institutional Randomized Trial Comparing Robot versus Open Radical CystectomyMaria F Becerra, Vivek Venkatramani, Isildinha M Reis, et al.
Journal for Immunotherapy of Cancer|September 17, 2025
Germline whole-exome sequencing reveals <i>FOXP3</i>-related gene variants conferring urinary cancer susceptibility and associated with immune escapeBing-Jian Feng, Wendy Kohlmann, David A Nix, et al.
The Journal of Urology|December 17, 2021
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final ReportSurena F Matin, Phillip M Pierorazio, Nir Kleinmann, et al.
The Lancet. Oncology|July 8, 2020
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trialNir Kleinmann, Surena F Matin, Phillip M Pierorazio, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Prostate Cancer|January 19, 2026
Change in Clinical Management of Localized Prostate Cancer Patients at a Tertiary Medical Center as a Result of SARS-CoV-2 (COVID-19)Alexander Yaney, Jonathan E Schoenhals, Yevgeniya Gokun, et al.
Cells|June 26, 2024
Patient-Derived Conditionally Reprogrammed Cells in Prostate Cancer ResearchAbdalla Elbialy, Deepthi Kappala, Dhruv Desai, et al.
World Journal of Urology|February 25, 2019
Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomyMichael A Feuerstein, Leah Goldstein, Brieyona Reaves, et al.
The Journal of Urology|January 4, 2020
Efficacy of Preoperative Chemotherapy for High Risk Upper Tract Urothelial CarcinomaBeat Foerster, Mohammad Abufaraj, Firas Petros, et al.
JAMA Network Open|February 16, 2022
Comparison of Robot-Assisted and Open Radical Cystectomy in Recovery of Patient-Reported and Performance-Related Measures of Independence: A Secondary Analysis of a Randomized Clinical TrialVivek Venkatramani, Isildinha M Reis, Mark L Gonzalgo, et al.
BJU International|January 28, 2015
The RAZOR (randomized open vs robotic cystectomy) trial: study design and trial updateNorm D Smith, Erik P Castle, Mark L Gonzalgo, et al.
The Journal of Urology|April 10, 2020
Health Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial: A Multi-Institutional Randomized Trial Comparing Robot versus Open Radical CystectomyMaria F Becerra, Vivek Venkatramani, Isildinha M Reis, et al.
Journal for Immunotherapy of Cancer|September 17, 2025
Germline whole-exome sequencing reveals <i>FOXP3</i>-related gene variants conferring urinary cancer susceptibility and associated with immune escapeBing-Jian Feng, Wendy Kohlmann, David A Nix, et al.
The Journal of Urology|December 17, 2021
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final ReportSurena F Matin, Phillip M Pierorazio, Nir Kleinmann, et al.
The Lancet. Oncology|July 8, 2020
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trialNir Kleinmann, Surena F Matin, Phillip M Pierorazio, et al.
Pageof 5